Epidermolysis Bullosa: all 85 studies
Page 1 of 1. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate ENERGI-F703EB Cream in Epidermolysis BullosaRecruitingNCT07858422Phase 2
- Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus PositionsRecruitingNCT07780981Not applicable
- Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of WoundsNot yet recruitingNCT07717736Phase 4
- An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis BullosaNot yet recruitingNCT07482813Phase 3
- Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis BullosaRecruitingNCT07482787Phase 3
- Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
- GMEB-SASS: A Gene-Modified Skin Substitute for RDEB TreatmentRecruitingNCT07193134Phase 1/2
- Thera-Clean® Microbubbles System in Patients With Skin DiseasesEnrolling by invitationNCT07050810Early Phase 1
- A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa SimplexRecruitingNCT07027345Phase 2
- Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)Not yet recruitingNCT07011589Phase 1/2
- A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis BullosaRecruitingNCT06917690Phase 3
- Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis BullosaRecruitingNCT06834035Phase 1/2
- A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-studyRecruitingNCT06594393Phase 2
- Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive CounsellingRecruitingNCT06330350
- Reproductive Options in Inherited Skin DiseasesEnrolling by invitationNCT06330324
- Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin DisordersRecruitingNCT05649098Early Phase 1
- Computational Drug Repurposing for All EBS CasesRecruitingNCT03269474
- A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis BullosaCompletedNCT03836001Phase 2Results posted
- To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)CompletedNCT03472287Phase 1Results posted
- Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa SimplexCompletedNCT03389308Phase 2Results posted
- Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis BullosaCompletedNCT03068780Phase 3Results posted
- Study of Cellutome System for Treatment of Individual Lesions in EB PtsCompletedNCT02670837Not applicableResults posted
- Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis BullosaTerminatedNCT02670330Phase 3Results posted
- Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB PatientsCompletedNCT02654483Phase 2Results posted
- MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCsCompletedNCT02582775Phase 2Results posted
- ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis BullosaCompletedNCT02384460Phase 3Results posted
- Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis BullosaTerminatedNCT02090283Phase 2Results posted
- Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis BullosaCompletedNCT02014376Phase 2Results posted
- Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of CareCompletedNCT01716169Not applicableResults posted
- Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)CompletedNCT01294241Phase 2Results posted
- Gene Transfer for Recessive Dystrophic Epidermolysis BullosaCompletedNCT01263379Phase 1/2Results posted
- Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCsCompletedNCT01033552Phase 1/2Results posted
- Study of Alwextin® Cream in Treating Epidermolysis BullosaCompletedNCT00825565Phase 2Results posted
- Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis BullosaTerminatedNCT00478244Not applicableResults posted
- A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis BullosaTerminatedNCT00311766Phase 2Results posted
- Topical Insulin Versus Irradiated Amniotic Fluid Gel for Wound Healing in Epidermolysis BullosaCompletedNCT07907523Not applicable
- Curcumin-Based Photodynamic Therapy in Epidermolysis Bullosa: Wound Healing, Quality of Life, and Salivary BiomarkersActive, not recruitingNCT07596927Phase 4
- Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of WoundsCompletedNCT07312513Not applicable
- Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis BullosaActive, not recruitingNCT06713434Phase 1
- Artificial Intelligence Patient App for RDEB SCCsActive, not recruitingNCT05843994
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)Active, not recruitingNCT05838092Phase 3
- A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated PatientsActive, not recruitingNCT05725018Phase 3
- Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis BullosaCompletedNCT05651607Phase 2
- Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray SolutionCompletedNCT05533866Early Phase 1
- Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 GeneStatus unknownNCT05529134Phase 1/2
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)Active, not recruitingNCT05464381Phase 3
- Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.CompletedNCT05378997Phase 1
- Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa.Status unknownNCT05288478Phase 2
- Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB)CompletedNCT05248503
- Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)CompletedNCT05143190Phase 2
- Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis BullosaStatus unknownNCT05141838Phase 4
- Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa SimplexCompletedNCT05062070Phase 1
- The State of Sexual Development in Children With Inherited Epidermolysis BullosaStatus unknownNCT05033574
- Improve Adherence to Weak or Strong Opioid Analgesics at the Time of Care in Children With Hereditary Epidermolysis BullosaCompletedNCT04853667
- Topical Gentamicin Nonsense Suppression Therapy of EBCompletedNCT04644627Phase 1/2
- The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III TrialWithdrawnNCT04613102Phase 2/3
- Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)CompletedNCT04227106Phase 3
- Observational Study of a Cohort of Patients With Hereditary Epidermolysis BullosaCompletedNCT04217538
- A Pilot Study to Explore the Role of Gut Flora in Epidermolysis BullosaWithdrawnNCT04213703
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
- Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa PatientsCompletedNCT03942250Not applicable
- Pregabalin Treatment for RDEB Pain and ItchCompletedNCT03928093Phase 3
- Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis BullosaCompletedNCT03730584Not applicable
- Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis BullosaTerminatedNCT03578029Phase 2
- Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis BullosaCompletedNCT03529877Phase 1/2
- A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB PatientsCompletedNCT03468322Phase 2
- A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical TrialCompletedNCT03183934
- Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis BullosaCompletedNCT03158662
- Topical BPM31510 3.0% Cream in Patients With Epidermolysis BullosaCompletedNCT02793960Phase 1
- Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis BullosaCompletedNCT02579369Phase 1/2
- Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis BullosaCompletedNCT01908088Phase 1
- A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not HealingTerminatedNCT01749306Phase 3
- A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis BullosaTerminatedNCT01619670Phase 4
- Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling MearaCompletedNCT01556308Not applicable
- A Pilot Study of HP802-247 in Dystrophic Epidermolysis BullosaWithdrawnNCT01528306Phase 2
- Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous KeratinocytesWithdrawnNCT01454687Not applicable
- Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral ErythromycinStatus unknownNCT01340235Phase 3
- Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys BullosaCompletedNCT00987142Phase 2
- Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)TerminatedNCT00881556Early Phase 1
- The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis BullosaCompletedNCT00380640Phase 2
- Study to Evaluate the Efficacy of Tetracycline in Epidermolysis BullosaWithdrawnNCT00336154Phase 4
- Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis BullosaCompletedNCT00014729Phase 1
- Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis BullosaCompletedNCT00004791
- Establishment of the National Epidermolysis Bullosa RegistryCompletedNCT00004761
- Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa AcquisitaCompletedNCT00004359Phase 2